Skip to main content
ChemPartner PharmaTech Co., Ltd. logo

ChemPartner PharmaTech Co., Ltd. — Investor Relations & Filings

Ticker · 300149 ISIN · CNE100000Y27 Shenzhen Stock Exchange Professional, scientific and technical activities
Open in API
Filings indexed 2,256 across all filing types
Latest filing 2017-05-11 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 300149

About ChemPartner PharmaTech Co., Ltd.

https://www.chempartner.com

ChemPartner PharmaTech Co., Ltd. is a global research and development organization providing comprehensive drug discovery and development services. Operating as a Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO), the company supports pharmaceutical and biotechnology clients through an integrated service platform. Core capabilities include medicinal chemistry, biology, pharmacology, drug metabolism and pharmacokinetics (DMPK), and toxicology. The organization also offers specialized expertise in biologics discovery, protein engineering, and antibody development. ChemPartner facilitates the transition from early-stage research to clinical development through its pharmaceutical development and manufacturing capabilities, utilizing advanced technology to accelerate the discovery and production of novel therapeutic agents.

Recent filings

Filing Released Lang Actions
关于重大资产重组停牌进展公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement from a company regarding the progress of a major asset restructuring (重大资产重组停牌进展公告). It details the timeline of stock suspension due to the restructuring, ongoing negotiations, due diligence, and the uncertainty of completing the restructuring within the suspension period. The document is relatively short (1626 characters) and serves as a progress update rather than a full report or detailed financial disclosure. It does not contain financial statements or comprehensive analysis but is a regulatory announcement about the status of a capital restructuring event. Therefore, it fits best under the category of Capital/Financing Update (CAP).
2017-05-11 Chinese
关于重大资产重组停牌进展公告
Regulatory Filings Classification · 95% confidence The document is a public announcement from a company regarding the progress of a major asset restructuring (重大资产重组停牌进展公告). It details the timeline of stock suspension due to the restructuring, ongoing negotiations, due diligence, and the uncertainty of the transaction's completion. The document is relatively short (1617 characters) and serves as a progress update rather than a full report or detailed financial disclosure. It does not contain financial statements or comprehensive analysis but rather periodic disclosure of the status of a major transaction. This fits the category of a Regulatory Filing (RNS) as it is a regulatory announcement about the status of a corporate event without constituting a full report or detailed financial document.
2017-05-04 Chinese
2016年年度股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is titled as a 2016 Annual General Meeting (AGM) resolution announcement for Quantum Hi-Tech (China) Biological Co., Ltd. It details the meeting date, voting procedures, attendance, and the voting results on various proposals including the 2016 annual reports, financial statements, profit distribution plan, and related party transactions. It also includes a legal opinion letter confirming the legality and validity of the meeting and voting process. The document is a formal announcement of the voting results from the AGM, not the full AGM materials or the annual report itself. The document length is 4061 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, the appropriate classification is Declaration of Voting Results & Voting Rights Announcements (DVA).
2017-04-27 Chinese
2016年年度股东大会的法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a legal opinion letter from a law firm regarding the 2016 Annual General Meeting (AGM) of Quantum Hi-Tech (China) Biological Co., Ltd. It details the procedures for convening and holding the AGM, qualifications of attendees, voting procedures, and the results of the shareholder votes on various agenda items including the 2016 annual reports and profit distribution plan. The document is not the actual annual report or financial statements but a legal opinion on the AGM process and voting results. This fits the definition of Declaration of Voting Results & Voting Rights Announcements (DVA), as it officially reports the voting outcomes of the AGM. The document length is over 5,000 characters and contains detailed voting results, not just an announcement of a report publication or a certification. Therefore, the correct classification is DVA with high confidence.
2017-04-27 Chinese
关于重大资产重组停牌进展公告
Regulatory Filings Classification · 95% confidence The document is a public announcement from a company regarding the progress of a major asset restructuring and the related stock trading suspension. It details the timeline of the suspension, the nature of the asset involved, ongoing negotiations, due diligence, and audit activities. The document is relatively short (1651 characters) and serves as a progress update rather than a full financial report or detailed restructuring plan. It does not contain financial statements or comprehensive analysis but is an official disclosure about the status of a significant corporate event. This fits the category of a Regulatory Filing (RNS) as it is a regulatory announcement about a corporate event without being a full report or detailed financial document.
2017-04-26 Chinese
2017年第一季度报告全文
Interim / Quarterly Report Classification · 100% confidence The document is titled as the "2017 年第一季度报告全文" which translates to "2017 First Quarter Report Full Text." It contains detailed financial data including income, profit, cash flow, asset and liability changes, shareholder information, risk factors, and business outlook for the first quarter of 2017. The presence of comprehensive financial statements and analysis for a period shorter than a full fiscal year (quarterly) confirms it is an Interim / Quarterly Report. The document length is substantial (15,000 characters), and it contains actual financial data and management discussion, not just an announcement or certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR).
2017-04-25 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.